C. Eugene Reeder

724 total citations
34 papers, 586 citations indexed

About

C. Eugene Reeder is a scholar working on Economics and Econometrics, Geriatrics and Gerontology and Psychiatry and Mental health. According to data from OpenAlex, C. Eugene Reeder has authored 34 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Economics and Econometrics, 8 papers in Geriatrics and Gerontology and 6 papers in Psychiatry and Mental health. Recurrent topics in C. Eugene Reeder's work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Pharmaceutical Practices and Patient Outcomes (8 papers) and Pharmaceutical Economics and Policy (6 papers). C. Eugene Reeder is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (9 papers), Pharmaceutical Practices and Patient Outcomes (8 papers) and Pharmaceutical Economics and Policy (6 papers). C. Eugene Reeder collaborates with scholars based in United States, United Kingdom and Belgium. C. Eugene Reeder's co-authors include W. Michael Dickson, Arthur A. Nelson, Paige Hall Smith, Mary Kay Fadden, Ann L. Coker, Paul Williams, Chris M Kozma, Linda M. Robison, Tracy L. Skaer and David A. Sclar and has published in prestigious journals such as Medical Care, JAMA Network Open and Clinical Therapeutics.

In The Last Decade

C. Eugene Reeder

33 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Eugene Reeder United States 15 226 111 102 89 77 34 586
Song Hee Hong United States 15 141 0.6× 114 1.0× 140 1.4× 160 1.8× 62 0.8× 46 583
Johanne Collin Canada 16 188 0.8× 125 1.1× 146 1.4× 236 2.7× 13 0.2× 62 865
Jeffrey C. Darnell United States 9 104 0.5× 128 1.2× 167 1.6× 171 1.9× 130 1.7× 13 520
Luís Midão Portugal 12 226 1.0× 156 1.4× 404 4.0× 123 1.4× 62 0.8× 32 832
Berhanu Alemayehu United States 7 147 0.7× 79 0.7× 53 0.5× 198 2.2× 59 0.8× 13 545
Brenda R. Motheral United States 16 394 1.7× 321 2.9× 200 2.0× 143 1.6× 16 0.2× 35 1.1k
Sheri L. Maddigan Canada 10 177 0.8× 77 0.7× 93 0.9× 153 1.7× 57 0.7× 12 635
Audrey Weymiller United States 14 210 0.9× 59 0.5× 53 0.5× 436 4.9× 32 0.4× 17 789
Leena Saastamoinen Finland 16 210 0.9× 112 1.0× 240 2.4× 87 1.0× 15 0.2× 56 803
Steven Burch United States 12 159 0.7× 131 1.2× 51 0.5× 82 0.9× 9 0.1× 17 615

Countries citing papers authored by C. Eugene Reeder

Since Specialization
Citations

This map shows the geographic impact of C. Eugene Reeder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Eugene Reeder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Eugene Reeder more than expected).

Fields of papers citing papers by C. Eugene Reeder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Eugene Reeder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Eugene Reeder. The network helps show where C. Eugene Reeder may publish in the future.

Co-authorship network of co-authors of C. Eugene Reeder

This figure shows the co-authorship network connecting the top 25 collaborators of C. Eugene Reeder. A scholar is included among the top collaborators of C. Eugene Reeder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Eugene Reeder. C. Eugene Reeder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Love, Bryan L., et al.. (2022). Applying mixture cure survival modeling to medication persistence analysis. Pharmacoepidemiology and Drug Safety. 31(7). 788–795. 1 indexed citations
2.
Reeder, C. Eugene, et al.. (2008). Managed care and the impact of glaucoma.. PubMed. 14(1 Suppl). S5–S10. 10 indexed citations
3.
Dickson, Michael, et al.. (2006). Drug and Medical Cost Effects of a Drug Formulary Change With Therapeutic Interchange for Statin Drugs in a Multistate Managed Medicaid Organization. Journal of Managed Care Pharmacy. 12(4). 331–340. 25 indexed citations
4.
Reeder, C. Eugene, et al.. (2006). Managing oncology costs.. PubMed. 12(1 Suppl). S3–16; quiz S17. 28 indexed citations
5.
Williams, Paul & C. Eugene Reeder. (2004). A Comparison of the Cost-Effectiveness of Almotriptan and Sumatriptan in the Treatment of Acute Migraine Using a Composite Efficacy/Tolerability End Point. Journal of Managed Care Pharmacy. 10(3). 259–265. 21 indexed citations
6.
Shinogle, Judith A., et al.. (2004). Effects of an Increase in Prescription Copayment on Utilization of Low-Sedating Antihistamines and Nasal Steroids. Journal of Managed Care Pharmacy. 10(3). 226–233. 12 indexed citations
7.
Coker, Ann L., C. Eugene Reeder, Mary Kay Fadden, & Paige Hall Smith. (2004). Physical Partner Violence and Medicaid Utilization and Expenditures. Public Health Reports. 119(6). 557–567. 78 indexed citations
8.
Williams, Paul & C. Eugene Reeder. (2003). Cost-effectiveness of almotriptan and rizatriptan in the treatment of acute migraine. Clinical Therapeutics. 25(11). 2903–2919. 19 indexed citations
9.
Kozma, Chris M, Victoria Barghout, Terra Slaton, Feride Frech, & C. Eugene Reeder. (2002). A comparison of office-based physician visits for irritable bowel syndrome and for migraine and asthma.. PubMed. 15(9). 40–3, 49. 12 indexed citations
10.
Reeder, C. Eugene, et al.. (2002). Economic comparison of oral triptans for management of acute migraine: implications for managed care.. PubMed. 8(3 Suppl). S80–4. 15 indexed citations
11.
Sclar, David A., et al.. (1999). Sulfonylurea Pharmacotherapy Regimen Adherence in a Medicaid Population: Influence of Age, Gender, and Race. The Diabetes Educator. 25(4). 531–538. 38 indexed citations
12.
Sclar, David A., et al.. (1998). Antidepressant Prescribing Patterns. Clinical Drug Investigation. 16(2). 135–140. 20 indexed citations
13.
Reeder, C. Eugene, et al.. (1998). ASHP survey of ambulatory care responsibilities of pharmacists in integrated health systems—1997. American Journal of Health-System Pharmacy. 55(1). 35–43. 10 indexed citations
14.
Kozma, Chris M & C. Eugene Reeder. (1997). Pharmacoeconomics. Disease Management & Health Outcomes. 2(2). 55–64. 2 indexed citations
15.
Pharm, D, et al.. (1994). Influence of Asthma or Allergies on the Utilization of Health Care Resources and Quality of Life of College Students. Journal of Asthma. 31(4). 251–267. 30 indexed citations
16.
Cox, Emily R., Chris M Kozma, & C. Eugene Reeder. (1994). Multivariate Analysis of Health Status Scores. PharmacoEconomics. 6(1). 49–56. 1 indexed citations
17.
Reeder, C. Eugene, et al.. (1993). Economic Impact of Cost-Containment Strategies in Third Party Programmes in the US (Part I)1. PharmacoEconomics. 4(2). 92–103. 19 indexed citations
18.
Reeder, C. Eugene, et al.. (1986). Perception of Business Related Graduate Degrees by Market Research Managers within the Health Care Industry. American Journal of Pharmaceutical Education. 50(3). 264–274. 2 indexed citations
19.
Nelson, Arthur A., C. Eugene Reeder, & W. Michael Dickson. (1984). The Effect of a Medicaid Drug Copayment Program on the Utilization and Cost of Prescription Services. Medical Care. 22(8). 724–736. 99 indexed citations
20.
Reeder, C. Eugene. (1983). Differential impact of copayment on drug utilization in the South Carolina medicaid program. University Microfilms International eBooks. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026